Modifying Cell Lines for Target Discovery and Validation In this 30-minute seminar, we will discuss the process of genome editing, address factors affecting the design of a genome editing project, and explore the application of modified cell lines for target discovery and validation.
Bacterial Genomic Changes Revealed through Next-generation Sequencing Data Analysis Lori Snyder, Kingston University, speaking at NSG & Big Data 2014
Detection and Characterization of Viable Circulating Tumor Cells Catherine Alix-Panabières, University Medical Center of Montpellier, speaking at Advances in Cellular Assays & Cell Culture 2014
Analysis of Gene and microRNA Function through High-Content Screening Miguel Mano, ICGEB Trieste, speaking at High Content Analysis 2014
Tumour Regression after Intravenous Administration of Novel Tumour-targeted Nanomedicines Christine Dufes, University of Strathclyde, speaking at Nanomedicine 2014.
Automated Injection of Cancer Cells in 3D ECM Scaffolds and Zebrafish Embryos for (Personalized) Compound Screening Jan De Sonneville, Life Science Methods B.V, speaking at High Content Analysis 2014
Circulating Tumor Cells as Liquid Biopsy for Cancer Patients Klaus Pantel, University Medical Center Hamburg Eppendorf, speaking at Advances In Cellular Assays & Cell Culture
Nanoparticle-mediated siRNA Gene Silencing against Brain Disorders Mariarosa Mazza, University of Manchester, speaking at Nanomedicine 2014.
Green Nanotechnology in Cancer Therapy Kattesh Katti, University of Missouri, speaking at Nanomedicine 2014.